{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:45:05Z","timestamp":1793040305024,"version":"4.5.0"},"reference-count":4,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The purpose of this guideline is to provide evidence-based guidance for the most effective strategies for the diagnosis and management of babesiosis. The diagnosis and treatment of co-infection with babesiosis and Lyme disease will be addressed in a separate Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR) guideline [1]. Recommendations for the diagnosis and treatment of human granulocytic anaplasmosis can be found in the recent rickettsial disease guideline developed by the Centers for Disease Control and Prevention [2]. The target audience for the babesiosis guideline includes primary care physicians and specialists caring for this condition, such as infectious diseases specialists, emergency physicians, intensivists, internists, pediatricians, hematologists, and transfusion medicine specialists.<\/jats:p>","DOI":"10.1093\/cid\/ciab050","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T22:17:00Z","timestamp":1611699420000},"page":"185-189","source":"Crossref","is-referenced-by-count":67,"title":["Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis"],"prefix":"10.1093","volume":"72","author":[{"given":"Peter J","family":"Krause","sequence":"first","affiliation":[{"name":"Yale School of Public Health and Yale School of Medicine, New Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G","family":"Auwaerter","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raveendhara R","family":"Bannuru","sequence":"additional","affiliation":[{"name":"Center for Treatment Comparison and Integrative Analysis (CTCIA), Division of Rheumatology, Tufts Medical Center, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A","family":"Branda","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yngve T","family":"Falck-Ytter","sequence":"additional","affiliation":[{"name":"Case Western Reserve University and VA Northeast Ohio Healthcare System, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M","family":"Lantos","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9ry","family":"Lavergne","sequence":"additional","affiliation":[{"name":"Research Center CIUSSS NIM, University of Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H Cody","family":"Meissner","sequence":"additional","affiliation":[{"name":"Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikala C","family":"Osani","sequence":"additional","affiliation":[{"name":"Center for Treatment Comparison and Integrative Analysis (CTCIA), Division of Rheumatology, Tufts Medical Center, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane Glazer","family":"Rips","sequence":"additional","affiliation":[{"name":"Healthcare Consumer Representative"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil K","family":"Sood","sequence":"additional","affiliation":[{"name":"Zucker School of Medicine and Cohen Children\u2019s Medical Center, Northwell Health, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Vannier","sequence":"additional","affiliation":[{"name":"Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizaveta E","family":"Vaysbrot","sequence":"additional","affiliation":[{"name":"Center for Treatment Comparison and Integrative Analysis (CTCIA), Division of Rheumatology, Tufts Medical Center, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary P","family":"Wormser","sequence":"additional","affiliation":[{"name":"New York Medical College, Valhalla, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"key":"2021012703151822400_CIT0001","volume-title":"Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease"},{"key":"2021012703151822400_CIT0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6502a1","article-title":"Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain Spotted Fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis - United States","volume":"65","author":"Biggs","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"2021012703151822400_CIT0003","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMra1202018","article-title":"Human babesiosis","volume":"366","author":"Vannier","year":"2012","journal-title":"N Engl J Med"},{"key":"2021012703151822400_CIT0004","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1542\/peds.2014-2026","article-title":"Azithromycin in early infancy and pyloric stenosis","volume":"135","author":"Eberly","year":"2015","journal-title":"Pediatrics"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/2\/185\/36115784\/ciab050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/2\/185\/36115784\/ciab050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T22:17:03Z","timestamp":1611699423000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/72\/2\/185\/6120630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":4,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,1,27]]},"published-print":{"date-parts":[[2021,1,27]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciab050","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1,15]]},"published":{"date-parts":[[2021,1,15]]}}}